207 related articles for article (PubMed ID: 7568631)
1. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.
Privette TH; Terrian DM
Psychopharmacology (Berl); 1995 Apr; 118(4):444-50. PubMed ID: 7568631
[TBL] [Abstract][Full Text] [Related]
2. κ Opioid receptor activation in different brain regions differentially modulates anxiety-related behaviors in mice.
Wang YJ; Hang A; Lu YC; Long Y; Zan GY; Li XP; Wang Q; Zhao ZX; He L; Chi ZQ; Liu JG
Neuropharmacology; 2016 Nov; 110(Pt A):92-101. PubMed ID: 27106167
[TBL] [Abstract][Full Text] [Related]
3. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
Leyton M; Stewart J
Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765
[TBL] [Abstract][Full Text] [Related]
4. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice.
Wall PM; Messier C
Brain Res; 2000 Feb; 856(1-2):259-80. PubMed ID: 10677636
[TBL] [Abstract][Full Text] [Related]
5. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
6. kappa-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1995 Aug; 281(2):173-8. PubMed ID: 7589204
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
8. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
Ukai M; Kameyama T
Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
[TBL] [Abstract][Full Text] [Related]
9. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test.
Motta V; Penha K; Brandão ML
Psychopharmacology (Berl); 1995 Aug; 120(4):470-4. PubMed ID: 8539329
[TBL] [Abstract][Full Text] [Related]
10. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
Shieh GJ; Walters DE
Neurosci Lett; 1994 Jul; 176(1):37-40. PubMed ID: 7970232
[TBL] [Abstract][Full Text] [Related]
11. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
13. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats.
McIntosh TK; Fernyak S; Yamakami I; Faden AI
Am J Physiol; 1994 Sep; 267(3 Pt 2):R665-72. PubMed ID: 7916537
[TBL] [Abstract][Full Text] [Related]
14. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
Marco EM; Llorente R; Pérez-Alvarez L; Moreno E; Guaza C; Viveros MP
Behav Brain Res; 2005 Sep; 163(2):212-8. PubMed ID: 15979169
[TBL] [Abstract][Full Text] [Related]
15. Chronic cocaine injections attenuate behavioral response of kappa-opioid receptors to U-50,488H agonist.
Kudryavtseva NN; Gerrits MA; Alekseenko OV; Van Ree JM
Bull Exp Biol Med; 2005 Sep; 140(3):320-2. PubMed ID: 16307048
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
17. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
19. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
20. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
Pugsley MK; Saint DA; Walker MJ
Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
